Recent work in rat and mouse models of obesity and IR demonstrate that pharmacologic activation of BCKA oxidation by the branched chain α‐keto acid dehydrogenase (BCKDH) complex improves insulin sensitivity while lowering circulating BCAAs and BCKAs.5, 6. The gene discussed is INS; the disease is obesity disorder.